Tweetovi

Blokirali ste korisnika/cu @Biotechnology

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Biotechnology

  1. prije 9 sati

    People with Disabilities Get Cancer Too

    Poništi
  2. prije 9 sati

    How Coronaviruses Cause Infection--from Colds to Deadly Pneumonia

    Poništi
  3. prije 9 sati

    What's Inside? Meat vs. Meatless Burgers

    Poništi
  4. 4. velj

    Can You Use Yoga to Improve Your Athletic Performance?

    Poništi
  5. 4. velj

    Coronavirus Is a Reminder: The Best Defense against a New Outbreak Is Early Detection

    Poništi
  6. 4. velj

    Penicillium Fungus Hosts Surprising Opioid Compounds 

    Poništi
  7. 3. velj

    Insmed's Shares Rocket as Phase II NCFBE Trial Hits Endpoints

    Poništi
  8. 3. velj

    Key Mechanisms to Capillary Loss in Diabetes, Heart Disease and Others Discovered

    Poništi
  9. 3. velj

    Former GSK Site in Pennsylvania Gets Revamped into Life Sciences Hub

    Poništi
  10. 1. velj

    Bayer's Nubeqa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer

    Poništi
  11. 1. velj
    Poništi
  12. 1. velj

    China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann

    Poništi
  13. 31. sij

    What To Say in the Exit Interview So You Leave on a Good Note

    Poništi
  14. 31. sij

    Another Example of How Health Care Disparities Kill

    Poništi
  15. 31. sij

    The FDA Is Approving Drugs Faster, But That May Not Be A Good Thing

    Poništi
  16. 30. sij

    Sanofi Sees Positive Results in Two Clinical Trials for Nieman-Pick Disease

    Poništi
  17. 30. sij

    Doctors, Will You Be Watching the Super Bowl?

    Poništi
  18. 30. sij

    Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

    Poništi
  19. 29. sij

    Should You Apply If You Don’t Meet All Qualifications?

    Poništi
  20. 29. sij

    Following Positive Phase II Results, Akcea to Turn Hypertriglyceridemia Asset Over to Pfizer

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·